|
Rivera-Caravaca JM, Soler-Espejo E, Ramos-Bratos MP, Lopez-Galvez R, Gonzalez-Lozano E, Lip GYH, Marin F, Roldan V. The triglyceride-glucose index, a marker of insulin resistance, as a predictor of thrombotic risk in atrial fibrillation. Cardiovasc Diabetol. 2025 Jul 10;24(1):281. doi: 10.1186/s12933-025-02809-2. PubMed PMID: 40640827; PubMed Central PMCID: PMC12247220.
AÑO: 2025; IF: 10.6
|
|
Soler-Espejo E, Chen Y, Rivera-Caravaca JM, Ramos-Bratos MP, Lopez-Galvez R, Marin F, Roldan V, Lip GYH. Remnant-to-LDL cholesterol discordance as a predictor of thromboembolic events in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF project III (MAFP-III) cohort study. Cardiovasc Diabetol. 2025 Jul 10;24(1):275. doi: 10.1186/s12933-025-02831-4. PubMed PMID: 40640836; PubMed Central PMCID: PMC12243276.
AÑO: 2025; IF: 10.6
|
|
Roldán V., Marín F., Gallego P., Vicente V., Lip G.Y.H. High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation: A reply to a rebuttal. Journal of Thrombosis and Haemostasis. November 2012. 10:2414-2415. 10.1111/j.1538-7836.2012.04918.x
AÑO: 2012; IF: 6.081
|
|
Teruel R., Pérez-Sánchez C., Corral J., Herranz M.T., Pérez-Andreu V., Saiz E., García-Barberá N., Martínez-Martínez I., Roldán V., Vicente V., López-Pedrera C., Martínez C. Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome. Journal of Thrombosis and Haemostasis. October 2011. 9:1985-1992. 10.1111/j.1538-7836.2011.04451.x
AÑO: 2011; IF: 5.731
|
|
Montoro-García S., Marín F., Roldán V., Lip G.Y.H. Is plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage?. Thrombosis Research. December 2011. 128:601-602. 10.1016/j.thromres.2011.07.005
AÑO: 2011; IF: 2.44
|